NCT07464951
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07464951
Title CART123 Cells With or Without Ruxolitinib in Relapsed/Refractory Acute Myeloid Leukemia (CART123)
Acronym CART123
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Stephan Grupp MD PhD
Indications
Therapies
Age Groups: adult | child
Covered Countries USA


No variant requirements are available.